Bausch + Lomb and Novaliq Announce Submission of New Drug Application for Investigational Treatment NOV03 (Perfluorohexyloctane)

VAUGHAN, ON and HEIDELBERG, Germany, July 7, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ( " Bausch + Lomb " ), a leading global eye health company dedicated to helping people see better to live...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news